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INTRODUCTION
Inflammation is broadly considered as a response to pathogens or tissue homeostatic imbalance (Kotas and Medzhitov, 2015) . Being a critical component of cellular homeostasis, iron metabolism is closely related to the inflammation in many distinct settings. For instance, during acute bacterial infection, the peptide hormone hepcidin produced by hepatocytes blocks iron exportation and leads to iron accumulation in macrophages (Ganz and Nemeth, 2012) . Iron deposition is also observed in affected tissues of autoinflammatory diseases, including the central nervous system (CNS) of patients with neuroinflammatory diseases (e.g., multiple sclerosis) or neuro-degenerative diseases (e.g., Alzheimer's disease and Parkinson's disease) and the synovial fluid from patients with rheumatoid arthritis (Baker and Ghio, 2009; Craelius et al., 1982; Haider et al., 2014) . Indeed, lowering systemic iron level was able to protect mice from experimental autoimmune encephalomyelitis (EAE) (Grant et al., 2003; Pedchenko and LeVine, 1998) and exhibited some benefit in patients with multiple sclerosis (Lynch et al., 2000; Weigel et al., 2014 ). These observations suggest a possible link between iron homeostasis and inflammatory response, yet the precise role and physiological significance of iron accumulation in inflammation remain elusive.
Proinflammatory helper T cells, including interferon (IFN)-gproducing T helper 1 (Th1) cells and interleukin (IL)-17A-or F-producing Th17 cells, are a major source of proinflammatory cytokines and critical mediators of autoinflammatory diseases. Granulocyte-macrophage colony-stimulating factor (GM-CSF) is a proinflammatory cytokine produced by various immune cells that promotes myeloid cell maturation and activation (Hamilton, 2002) . GM-CSF produced by helper T (Th) cells is indispensable for the pathogenesis of many autoimmune diseases (e.g., autoimmune encephalomyelitis, myocarditis, and arthritis) (Campbell et al., 1998; Codarri et al., 2011; El-Behi et al., 2011) ; however, molecular mechanisms regulating GM-CSF expression in T cells remain to be fully elucidated. Like many cytokines, GM-CSF messenger (m)RNA contains an adenosine uridinerich element (ARE) in its 3 0 untranslated regions (3 0 UTRs), a component that recruits RNA-binding proteins (RBPs), including tristetraprolin (TTP) (Carballo et al., 2000) or AU-rich element RNA-binding protein 1 (AUF1) (Shen et al., 2005) , to degrade the GM-CSF mRNA. Other RBPs, such as ELAV-like protein 1 (also known as HuR) (Fan and Steitz, 1998) , antagonize TTP function, promoting the stability and translation of GM-CSF and other ARE-containing mRNAs (Kafasla et al., 2014) . A mutant GM-CSF 3 0 UTR reporter lacking the ARE is still responsive to PMA stimulation, suggesting that other cis-regulatory elements and trans-acting factors also participate in the stability regulation of GM-CSF mRNA (Iwai et al., 1991) .
Post-transcriptional regulation of gene expression is mediated by RBPs, emerging as important factors implicated in many human diseases as well as in normal physiology. Recent proteomic analysis has revealed that many RBPs have metabolic activities (Baltz et al., 2012; Castello et al., 2012) . In CD8 + T cells, a glycolysis enzyme, glyceraldehyde 3-phosphate dehydrogenase (GAPDH), regulates the translation of IFN-g mRNA through interaction with its 3 0 UTR ARE (Chang et al., 2013) . However, it is generally unclear how metabolic homeostasis interplays with RBPs and the biological significance of such interplays. Most studies on RBPs focus on identifying their target RNAs, while little is known about how RBP activity is modulated in response to environmental cues to reshape the transcriptome.
In this study, we demonstrated that iron was able to directly participate in inflammatory responses by promoting proinflammatory cytokine production in the T cells via poly(rC)-binding protein 1 (Pcbp1), an RBP with iron chaperon activity. Intracellular iron depletion or Pcbp1 deficiency in autoreactive T cells resulted in shortened mRNA half-life and diminished GM-CSF production, protecting mice against EAE. Conversely, iron overload induced by iron dextran enhanced GM-CSF production of T cells via Pcbp1 in EAE. Mechanistically, intracellular iron protected Pcbp1 protein from caspase-mediated proteolysis, and Pcbp1 promoted mRNA stability by recognizing UC-rich elements in the 3 0 UTRs. Thus, our data indicate that Pcbp1 acts as an iron sensor to relay this metabolic signaling to cytokine production, suggesting that clinically observed iron deposition may precipitate autoimmune diseases by promoting proinflammatory cytokine production.
RESULTS

Intracellular Iron Promotes GM-CSF Production in T Cells
To investigate potential roles of iron in inflammation, we examined how iron regulates cytokine production in helper T cell subsets. Th1 and Th17 cells were differentiated in vitro and treated with an intracellular iron chelator, ciclopirox olamine (CPX), a hydroxypyridone that penetrates plasma membranes and binds intracellular iron (Eberhard et al., 2009) . Acute CPX treatment (4 hr) led to a $30% reduction of IFN-g-producing Th1 cells ( Figure 1A ) and IL-17A-producing Th17 cells ( Figure S1A ). In both Th1 and Th17 cells, CPX treatment suppressed more than 70% of GM-CSF-producing cells (Figures 1A and S1A) . CPX treatment selectively suppressed GM-CSF and IL-2 expression in a dosage-dependent manner in both Th1 (Figure 1B) and Th17 ( Figure S1A ) cells, whereas tumor necrosis factor a (TNF-a) and IFN-g expression were reduced only at higher doses ( Figure S1B ). IFN-g + GM-CSF + (Th1) and IL-17A + GM-CSF + (Th17) cells were most sensitive to CPX treatment, while IFN-g or IL-17A single-positive cells were mostly refractory to CPX. Similar to CPX, deferoxamine (DFO), an extracellular iron chelator, also efficiently suppressed the production of GM-CSF ( Figures 1C and 1D ). This effect could be partially reversed Figure S1 .
by supplementing the culture with excess ferrous iron (Figure 1C) . IL-2 expression was less sensitive to DFO than to CPX in the Th1 cells ( Figure S1D ). CPX, but not DFO, induced appreciable cell death and cell cycle arrest at higher concentrations. Nevertheless, at lower concentrations, CPX sufficiently suppressed GM-CSF and IL-2 production without causing substantial cell survival or proliferation defects ( Figures 1A, 1B , and S1C-S1E). Thus, the two structurally distinct iron chelators were both able to suppress GM-CSF production in the T cells. Conversely, iron overload by iron dextran supplementation promoted the expression of pro-inflammatory cytokines, including GM-CSF in Th1 cells (Figures 1E and 1F) . Such effects could not be reverted by an antioxidant, N-acetylcysteine (NAC), implying that they were independent of pro-oxidant effects associated with iron overload.
In addition to murine T cells, CPX treatment significantly inhibited GM-CSF and IL-2 production in primary human T cells, while IFN-g expression was only mildly suppressed ( Figure 1G ), highlighting the evolutionarily conserved function of iron in promoting GM-CSF expression. Taken together, these data indicate that iron promotes the production of GM-CSF, IL-2, and multiple pro-inflammatory cytokines in T cells, with GM-CSF being the one most sensitive to intracellular iron homeostasis.
Iron Promotes GM-CSF Production in Autoreactive T Cells during Neuroinflammation
As GM-CSF production by T cells is indispensable for the pathogenesis of EAE (Codarri et al., 2011; El-Behi et al., 2011) , we examined the role of iron in cytokine production of T cells in neuroinflammation. TfR1 (encoded by Tfrc) is the primary iron transporter at the plasma membrane, the deficiency of which reduces iron uptake and the level of intracellular labile iron (Sargent et al., 2005) . We crossed Tfrc fl/fl with Cd4-Cre mice to deplete Tfrc in T cells beyond the double-positive stage in the thymus. In contrast to a previous study, which showed that Tfrc-deficient hematopoietic stem cells failed to develop into T cells in Rag1 À/À mice (Ned et al., 2003) , T cells in the Tfrc-deficient mice developed normally in the thymus ( Figure S2A ). In the periphery, CD4 + T cells were slightly reduced (Figures S2A and S2B) and contained fewer effector or memory cells (CD44 hi CD62L lo ) in the Tfrc-deficient mice than in the WT littermates ( Figure S2C ). Consistent with previous studies using antibody blockade (Kemp et al., 1987) , Tfrc-deficient CD4 T cells displayed proliferation defects in response to TCR stimulation in vitro (data not shown). Tfrc-deficient mice were protected from EAE induced by MOG-CFA immunization, manifesting reduced disease incidence and less severe clinical symptoms (Figures 2A and 2B ). In addition, fewer Tfrc-deficient CD4 T cells accumulated in the CNS ( Figure S2D ), which produced less pro-inflammatory cytokines, including GM-CSF, IL-2, and IFN-g ( Figures 2C and 2D ).
To further demonstrate the effects of Tfrc deficiency on effector T cells, we acutely depleted Tfrc in the CNS-infiltrating T cells in mice with active EAE. 2D2 transgenic T cells recognize myelin oligodendrocyte glycoprotein (MOG) peptide, a major auto-antigen in EAE (Bettelli et al., 2003) . We transduced 2D2 Tfrc fl/fl CD4 T cells with retrovirus containing a self-deleting
Cre-ERT2 gene (Zhao et al., 2010) and transferred the cells into sub-lethally irradiated WT recipients to induce EAE (Bandukwala et al., 2012) . At the early stage of the disease (EAE clinical score = 1), the mice were treated with tamoxifen to acutely delete the floxed Tfrc alleles in the transferred 2D2 T cells. Four days after the treatment, ERT2-Cre + 2D2 T cells selectively downregulated the expression of GM-CSF and IL-2 in the tamoxifentreated mice compared to in the mock-treated mice, while the expression of IFN-g and TNF-a was not affected (Figures 2F and 2G) . The acute deletion of Tfrc did not suppress proliferation, survival, or accumulation of effector 2D2 T cells in the CNS (Figures 2H , S2E, and S2F). In addition, the acute depletion of Tfrc repressed ongoing neuroinflammation and rescued the mice from full clinical symptoms of EAE ( Figure 2E ). Together, these data indicate that iron uptake through TfR1 is essential for GM-CSF production and encephalitogenicity of effector T cells.
Conversely, iron overload promoted pro-inflammatory cytokine production in auto-reactive T cells. In EAE induced by 2D2 T cells, the recipients were treated with iron dextran to induce systemic iron overload. Iron dextran enhanced GM-CSF expression by more than 50% in 2D2 Tg T cells recovered from the inflamed CNS, whereas IFN-g and TNF-a were only mildly increased by $20% (Figures 2I and 2J ). Despite enhanced cytokine production, neither accumulation nor survival of 2D2 T cells was affected (Figures S2G and S2H) . Cytokine production of either the 2D2 donor cells or the endogenous T cells in the periphery was also upregulated following the iron dextran treatment ( Figures 2I and 2J ). In contrast, TNF-a expression of either infiltrating myeloid cells or resident microglia in the CNS was only slightly upregulated in the iron dextran-treated mice (Figures S2I and S2J) . These data indicate that iron promotes the production of pro-inflammatory cytokines in auto-reactive T cells in vivo, suggesting a previously unappreciated function of iron in neuroinflammation.
Iron Promotes Stability of GM-CSF mRNA in the T Cells RNA stability is one of the key mechanisms regulating GM-CSF expression. It is primarily mediated through 3 0 UTR via interaction with specific RBPs (Anderson, 2008) . To test whether intracellular iron is able to modulate GM-CSF 3 0 UTR activities, we generated a fluorescence reporter by cloning the 3 0 UTR sequence of CSF2 mRNA (encodes GM-CSF) to the 3 0 end of the destabilized yellow fluorescent protein (ddYFP) gene ( Figure S3A ). As expected, the reporter expression was upregulated in response to PMA and ionomycin stimulation ( Figure S3B ). After a 12-hr CPX treatment, we observed a reduction of more than 80% of the reporter activity relative to the control treatment ( Figure 3A) , which was partially reversed by iron dextran. Although CPX led to a minor increase of cell death in the Jurkat cells ( Figure 3B ), viable cells (Annexin V À PI À ) also demonstrated reduced reporter activity ( Figure 3C ).
A similar reduction of reporter activity was observed with DFO treatment, which was reverted by excessive ferrous iron (Figure 3D ). Conversely, Hemin, which increases the intracellular iron concentration, enhanced the reporter activity and was countered by the iron chelator DFO ( Figure 3F ). Unlike CPX, neither DFO nor Hemin caused appreciable cellular death (Figures 3E and 3G) or proliferation defects ( Figure S2K ). Consistent with the reduced 3 0 UTR activity, the half-life of Csf2 mRNA was significantly shortened under the iron-depleted conditions, as determined by a 4-thiouridine (4SU) pulse-chase assay (Tani and Akimitsu, 2012) in either Jurkat T cells or primary murine Th1 cells ( Figure 3H ). Although total GM-CSF transcripts were significantly reduced, the transcription rate of GM-CSF mRNA was not appreciably suppressed by the CPX treatment ( Figure 3I ). We thus conclude that intracellular iron promotes GM-CSF production in T cells primarily by enhancing its 3 0 UTR activity and mRNA stability.
shRNA Screening Identifies PCBP1 as a Regulator of GM-CSF mRNA Stability In order to identify RBPs that mediate iron signaling to regulate GM-CSF production, we carried out a short hairpin RNA (shRNA) screening for RBPs regulating GM-CSF 3 0 UTR activity. Based on protein domain prediction of RBPs with potential functions in regulating mRNA stability and/or translation (Anderson, 2008) , we assembled an shRNA library from The RNAi Consortium (TRC) containing $240 shRNAs against 78 RBPs, each with three independent shRNAs ( Figure S3C ). Cells expressing the GFP-(CSF2)-3 0 UTR reporter were transduced with individual shRNA, and GFP expression was determined by flow cytometry following puromycin selection.
As expected, HuR and TTP were among the top hits of positive and negative regulators in the screening ( Figure 4A ). PCBP1, an RBP with iron chaperone activity (Nandal et al., 2011; Shi et al., 2008) , was among the top positive hits in two independent screenings ( Figures 4A and S3D ). PCBP1 depletion in the reporter cells reduced GFP expression by more than 40% ( Figure S3E ). Among the three KH domains of the PCBP1 protein, only the third KH domain was required for its function in enhancing the CSF2 3 0 UTR activity (Figure S3F ). Moreover, PCBP1 was able to promote the activity of a mutant GM-CSF 3 0 UTR reporter lacking ARE, to a comparable degree as the WT 3 0 UTR reporter ( Figure S3G ). These data together demonstrated that PCBP1 enhanced GM-CSF 3 0 UTR activity, in a manner independent of the AREs. Consistent with the reduced 3 0 UTR activity, PCBP1 knockdown in the Jurkat cells ( Figure 4B ) significantly reduced GM-CSF and IL-2 expression ( Figures 4C and 4D ), and PCBP1 overexpression increased the mRNA levels of GM-CSF and IL-2 by almost 30-fold and 5-fold, respectively ( Figure S3H ). RNA immunoprecipitation (RIP) experiments further demonstrated that PCBP1 directly associated with GM-CSF and IL-2 mRNA ( Figure S3I ). PCBP1 was initially identified as an RBP that promotes a-globulin expression and is involved in cancer metastases, epithelialmesenchymal transitions, the anti-viral interferon response, and erythroid development (Chaudhury et al., 2010; Cho et al., 2013; Ho et al., 2013; Hussey et al., 2011; Ji et al., 2013; Ryu et al., 2017; Zhou et al., 2012) . To test whether PCBP1 regulates cytokine expression in primary T cells, we transduced Th1 cells with two independent shRNAs against Pcbp1 ( Figure 4E ). Silencing of Pcbp1 had no effect on Th1 cell survival or proliferation ( Figures  S4A and S4B) . GM-CSF expression in the Pcbp1 knockdown cells was significantly suppressed compared to the control cells, as determined by intracellular cytokine staining ( Figures 4F, S4C , and S4D), real-time RT-PCR ( Figure 4G ), or CBA assays (Figure S4E) . Expression of IFN-g, TNF-a, and IL-2 was also impaired in the Pcbp1-deficient cells albeit to a lesser degree than GM-CSF ( Figures 4F, 4G , and S4C-S4F). Tbet, a key transcription factor regulating cytokine genes in Th1 cells, remained unchanged upon Pcbp1 knockdown ( Figure S4G ). Co-culture experiments further demonstrated that only the shPcbp1-transduced cells manifested attenuated GM-CSF production ( Figure S4H ), indicating a cell-autonomous function of Pcbp1 in promoting cytokine expression. Conversely, overexpression of PCBP1 enhanced GM-CSF expression ( Figure 4H ). Finally, PCBP1 knockdown significantly reduced the stability of GM-CSF and IL-2 mRNA ( Figure 4I ), while it had little effect on the translation efficiency of GFP/CSF2-3 0 UTR fusion transcripts ( Figure S3J ). Taken together, these experiments validate that PCBP1 promotes endogenous expression of pro-inflammatory cytokines, primarily GM-CSF and IL-2, by enhancing their mRNA stability. Remarkably, the selective downregulation of GM-CSF and IL-2 in the Pcbp1-deficient T cells resembled our observation in the iron-deficient T cells.
PCBP1 Expression in T Cells Is Indispensable for the Pathogenesis of EAE
To examine the function of Pcbp1 in vivo, we reconstituted Rag1 À/À mice with WT bone marrow cells transduced with either shPcbp1 or shCtrl. Six weeks after the reconstitution, either in the thymus or in the spleen of the chimeric mice, >90% of the T cells expressed GFP, indicating they were derived from the donor bone marrow cells. These Pcbp1-deficient T cells developed normally in the thymus and the CD4 T cells had an activation status comparable to their WT counterparts in the periphery, whereas the Pcbp1-deficient CD8 T cells had lower expression of CD44 ( Figures S5A and S5B ). We next immunized the chimeric mice with MOG and CFA to induce EAE and found that the mice with Pcbp1-deficient T cells were protected from the disease, with reduced disease incidence and less severe clinical symptoms compared to the control mice ( Figures 5A and 5B) . In CNS-infiltrating T cells, we found that Pcbp1-deficient T cells expressed much less GM-CSF, while they presented comparable IFN-g expression ( Figures 5C and 5D ), resembling the Pcbp1-deficient phenotypes in vitro. Cellular viability of the Pcbp1-deficient T cells in the CNS was comparable to that of the WT cells ( Figures S5C and S5D ).
We also examined the function of Pcbp1 in the EAE model induced by the adoptive transfer of 2D2 TCR transgenic T cells. 2D2 CD4 T cells were activated in vitro, transduced with shPcbp1-or control shRNAs (shCtrl)-expressing retroviruses, and transferred into recipient mice. All the mice receiving T cells with control shRNA developed EAE and manifested typical ascending paralysis symptoms ( Figures 5E-5G ) as well as weight loss ( Figure 5H ). The mice receiving the Pcbp1-deficient T cells had only minor clinical symptoms ( Figures 5E, 5G , and 5H) despite the similar disease incidence ( Figure 5F ). We then analyzed pro-inflammatory cytokine expression of the transferred 2D2 T cells in vivo. Either at the early stage of the disease (day 16 after the adoptive transfer, EAE score = 0.5 for both the shCtrl and the shPcbp1 groups) or at the peak stage of the disease (day 21 after the transfer, EAE score = 4 for the shCtrl and 1 for the shPcbp1 group, respectively), Pcbp1-deficient 2D2 T cells expressed much less GM-CSF than the control cells, whereas the expression of IFN-g and TNF-a was not altered (Figures 5I and 5J) , resembling the phenotypes of the Tfrc-deficient 2D2 T cells in vivo ( Figure 2G ). Despite reduced disease severity, the numbers of the Pcbp1-deficient 2D2 T cells (CD4 + Vb11 + ) in the CNS or in the periphery and their proliferation and viability were comparable to the control cells ( Figures S5D-S5H ), suggesting that Pcbp1 was not required for 2D2 T cell survival and/or migration to the CNS. Although numbers and composition of myeloid cells in the CNS were not significantly changed in the mice receiving Pcbp1-deficient 2D2 T cells ( Figures S5I  and S5J ), CD45 int
CD11b
+ microglial cells expressed much less MHC II than their counterparts in the mice with control 2D2 T cells, in concordance with a recent report showing that T cell-derived GM-CSF promotes activation of CNS-resident microglia ( Figure S5K ; Codarri et al., 2011) .
To demonstrate the T cell-intrinsic function of Pcbp1 in vivo, we mixed untransduced 2D2 T cells with 2D2 cells transduced with the shPcbp1 or shCtrl retrovirus and transferred the mixed cells into Thy1.1 congenic mice to induce EAE. As expected, all the mice developed the disease similarly. Yet, even in the recipient mice with strong inflammation in the CNS, Pcbp1-deficient T cells (Thy1.2 + Ametrine + ) expressed much less GM-CSF than the control cells ( Figure 5K ). Again, IFN-g and GM-CSF co-expressing cells, but not IFN-g single-positive CD4 cells, were abolished in the Pcbp1-deficient T cells, confirming a T cell-intrinsic function of Pcbp1 in promoting GM-CSF expression in vivo. Further supporting the role of Pcbp1 in promoting GM-CSF production, silencing Pcbp1 in OT-II T cells selectively repressed expression of GM-CSF and IL-2 in response to OVA immunization while maintaining expression levels of IFN-g and TNF-a similar to the control cells ( Figure S5K ). Thus, Pcbp1 is indispensable for GM-CSF production in autoreactive T cells in vivo and is essential for T cell-induced autoimmune encephalomyelitis. Supporting the importance of PCBP1 in neuroinflammation, expression of PCBP1 in CNS lesions of patients with multiple sclerosis was elevated in comparison to normal-appearing white matter (NAWM) of the same patients or brain tissues from normal donors ( Figure 5L ; Hametner et al., 2013 ).
PCBP1 Recognizes UC-Rich Elements in 3
0 UTRs To identify global targets and gain mechanistic insights into PCBP1 function, we utilized crosslinking and immunoprecipitation (CLIP) experiments to map transcriptome-wide PCBP1 binding sites in Jurkat T cells (Jensen and Darnell, 2008; Licatalosi et al., 2008; Van Nostrand et al., 2016) . Consistently, more than 8,000 genes and 25,000 PCBP1-binding sites were identified in two independent CLIP experiments, suggesting the transcriptome-wide activity of PCBP1 in regulating RNA metabolism ( Figures 6A and 6B ). PCBP1-binding sites preferentially located within coding exons (42%) and 3 0 UTRs (37%) relative to their genomic distributions ( Figure 6C ), in agreement with its predominant cytoplasmic localization ( Figure S6A ). PCBP1 binding sites located in the 3 0 UTRs also had higher signal-to-background ratios (Log 2 IP/input) than those in the introns or the exons (Figure S6B) , confirming its preferential binding to 3 0 UTRs. Although PCPB1 predominantly binds to 3 0 UTRs, analysis of global gene expression revealed that PCBP1-binding mRNAs were not significantly changed in response to PCBP1 knockdown compared to unbound RNAs (data not shown), suggesting functional redundancy of PCBP1 with other RBPs in global regulation of RNA stability or the possibility that PCBP1 has functions beyond regulating RNA stability (e.g., mRNA translation regulation) when associated with 3 0 UTRs. Motif analysis revealed that PCBP1-binding sites were enriched in UC-rich elements, e.g., UUUCCC motifs in coding exons, 3 0 UTRs, and introns ( Figure 6D ). Poly U stretches in the PCBP1 binding sites can potentially be recognized by HuR (Lebedeva et al., 2011; Ló pez de Silanes et al., 2004; Mukherjee et al., 2011) in addition to its canonical AUUUA motifs. We thus integrated the PCBP1 binding sites with previously reported HuR CLIP in 293T cells and identified 1,636 binding sites shared by HuR and PCBP1 (with at least one overlapping nucleotide). Such a degree of overlap is likely an underestimate due to different transcriptomes of Jurkat T cells and 293T cells. Nonetheless, more than 70% of PCBP1 and HuR co-binding sites were located in 3 0 UTRs, a further enrichment from 37% or 35% 3 0 UTR-localized clusters of PCBP1 or HuR, respectively ( Figure S6C ). As an example, both HuR and PCBP1 bind to the same regions in 3 0 UTR of MRPS35 and SPRED1 mRNA, which contain UUUCCC motifs as potential binding sites of these two RBPs (Figures S6D and S6E ). Therefore, although PCBP1 acts independently of the canonical AREs, it shares the UUUCCC motif with HuR, suggesting cooperation between these two RBPs in regulating gene expression in some cases at 3 0 UTRs. Further supporting this notion, we found that the HuR protein was associated with PCBP1 in co-immunoprecipitation experiments ( Figure S6F ).
To systemically identify Pcbp1-regulated genes in the T cells, we performed RNA sequencing (RNA-seq) analysis comparing the Pcbp1-deficient (shPcbp1) to the control (shCtrl) murine Th1 cells. Applying criteria of a >2-fold change and RPKM (reads per kilo per million sequences) R 5 in at least two out of four samples, we found 436 and 530 genes significantly upregulated and downregulated, respectively, in the Pcbp1-deficient cells compared to the control cells ( Figure 6G , Table S1 ). Among the downregulated genes, many are cytokines and cytokine receptors involved in inflammation, including Ifng, Csf-2, and Il-2 ( Figures 6F, 6G , and S6G). Many histone mRNAs were also downregulated in the Pcbp1-deficient cells (Figures 6G and S6G) , suggesting that Pcbp1 participates in the nuclear organization. Upregulated genes are involved in RNA processing, indicating possible compensatory effects upon loss of Pcbp1 (Figures 6G and S6G) . Some of the significantly altered genes were validated by real-time PCR ( Figure S6H ). Similar to our observations in Jurkat T cells, Pcbp1-binding sites in the primary T cells were also enriched in the exons and 3 0 UTRs containing UC-rich elements ( Figure S6I ). Pcbp1 specifically bound to the 3 0 UTR of GM-CSF mRNA and to the 3 0 end of the last coding exon of IL-2, two of the most impaired genes in the absence of Pcbp1 ( Figure 6E ). The binding sites of Pcbp1 to GM-CSF and IL-2 are different from the known ARE on these mRNAs (Figure 6E) , further confirming that Pcbp1 recognizes novel cis-elements in regulating 3 0 UTR activity. Taken together, our findings indicate that Pcbp1 deploys a novel posttranscriptional mechanism to regulate gene expression. Iron Protects PCBP1 from Caspase-Induced Proteolysis Other than being an RBP, PCBP1 associates with ferrous iron in the cytoplasm and delivers it to non-heme iron proteins (Nandal et al., 2011; Shi et al., 2008) . However, whether the iron-binding capacity of PCBP1 is involved in the RNA processing and gene regulation is unexplored. Since Pcbp1 deficiency phenotypically resembled iron depletion in T cells, we went on to test whether iron regulates PCBP1 expression and activity.
After only 8 hr of treatment with CPX or DFO, PCBP1 protein levels were substantially reduced both in Jurkat T cells and in primary CD4 T cells. PCBP1 became almost undetectable 24 hr post-treatment ( Figures 7A, 7B , and S7A). The reduction of PCBP1 induced by DFO was countered by excessive ferrous iron ( Figures 7B and S7B) . Accompanying the reduction of the full-length PCBP1 protein levels, a smaller fragment of PCBP1 was detected in the CPX-treated Jurkat cells ( Figure S7C ), suggesting proteolysis of the PCBP1 protein. The chelator-mediated PCBP1 degradation was partially reversed by a pan-caspase inhibitor (Z-VAD-FM) ( Figures 7C, S7B , and S7C) but not by a proteasome inhibitor, a serine and cysteine proteases inhibitor or a lysosome inhibitor ( Figure S7D ). In addition to inducing Pcbp1 degradation, iron depletion by either CPX or DFO abrogated Pcbp1's activity in promoting GM-CSF expression in primary Th1 cells ( Figure 7D ). Conversely, iron overload via iron dextran supplementation enhanced Pcbp1 protein expression in primary T cells ( Figures 7E and 7F) , demonstrating that Pcbp1 expression is dynamically regulated by intracellular iron.
Consistent with the in vitro observations, Pcbp1 was elevated in the CNS-infiltrating 2D2 T cells compared to the cells in the periphery ( Figure S7E ), accompanied by increased ferritin expression, a surrogate marker for the intracellular iron level (Figures S7F and S7G; Munro, 1990) . The coordinated upregulation of Pcbp1 and ferritin was also observed in the CNS-infiltrating myeloid cells (Figures S7H and S7I) . Furthermore, TCR stimulation induces elevation of intracellular iron in the T cells ( Figures  S7K and S7L) , accompanied by increased expression of Pcbp1 ( Figure S7J ). Therefore, intracellular iron protects PCBP1 from caspase-mediated proteolysis in T cells, and Pcbp1 expression is correlated with the intracellular iron level in vivo.
Iron Promotes GM-CSF Expression via PCBP1
Finally, we show that iron regulates cytokine expression primarily through modulating expression and/or activity of PCBP1. Alteration of the intracellular iron concentration in the absence of PCBP1 failed to change the 3 0 UTR activity or expression of Figures 7G-7K ). Unlike WT Jurkat cells, an increase of intracellular iron with Hemin failed to enhance the GM-CSF 3 0 UTR reporter activity in the PCBP1-deficient cells ( Figure 7G ). Depletion of iron with CPX suppressed the 3 0 UTR reporter activity and endogenous GM-CSF expression in the WT, but not in the PCPB1-deficient Jurkat or primary T cells (Figures 7H-7K) .
GM-CSF (
In the Pcbp1-deficient T cells, iron overload failed to enhance GM-CSF production. In the Pcbp1-deficient 2D2 T cells, iron dextran only mildly increased GM-CSF production ( Figure 7L , from 18.9% to 26.3%) in vivo, a magnitude much less than in the control 2D2 T cells ( Figure 7L , from 28.7% to 48.2%). In contrast, the promotion of IFN-g expression by iron dextran was not countered by the absence of Pcbp1 (Figures 7L and  7M) , consistent with our finding that GM-CSF, but not IFN-g, is a direct target of Pcbp1. These data together demonstrate that iron post-transcriptionally promotes GM-CSF expression primarily via Pcbp1 in auto-reactive T cells.
DISCUSSION
In summary, our study identified PCBP1 as a critical regulator of GM-CSF production in T cells which is indispensable for the pathogenesis of EAE. As an RBP, PCBP1 is stabilized by intracellular iron, thus coupling iron homeostasis to pro-inflammatory cytokine production, which in turn enhances target mRNA stability and promotes the production of pro-inflammatory cytokines. Our study establishes a mechanistic link between post-transcriptional gene regulation and iron metabolism, suggesting that iron deposition can directly promote inflammation and precipitate inflammatory diseases.
Upon entry into the CNS, auto-reactive T cells undergo reactivation by myelin antigens to produce pro-inflammatory cytokines in EAE (Fl€ ugel et al., 2001; Kivis€ akk et al., 2009) . Our result suggests that local iron accumulation in the CNS represents an important parallel mechanism to promote cytokine production during T cell reactivation. GM-CSF has been to known to play a vital role in mediating EAE. We found that GM-CSF is most sensitive to iron overload, iron depletion, or Pcbp1 depletion in all the experimental settings among all the cytokines produced by auto-reactive T cells, highlighting the importance of the iron-PCBP1-GM-CSF axis in the pathogenesis of EAE and possibly other auto-inflammatory diseases.
In patients with multiple sclerosis, abnormal iron accumulation in the CNS (Craelius et al., 1982; LeVine and Chakrabarty, 2004) is positively correlated with the disease severity (Mehta et al., 2013) . A similar observation has been made in neurodegenerative diseases (Bartzokis et al., 1999; Raven et al., 2013) , in which inflammation is increasingly appreciated to be a critical component of the pathogenesis. It has been suggested that neuronal damage and myelin breakdown release iron, and accumulated iron subsequently induces oxidative stress, which exaggerates tissue damage (Hametner et al., 2013) . However, iron accumulation is often found at the early stage of multiple sclerosis rather than the chronic phrase, suggesting that iron accumulation may be more closely related to the early inflammatory response. Our study indicates that excess iron can directly precipitate autoimmune diseases by promoting pro-inflammatory cytokine production, thus providing new therapeutic opportunities for these diseases. A better understanding of iron function in inflammation together with more potent and safe iron chelators will likely lead to better prognosis for these diseases in the future.
Although PCBP1 stabilizes cytokine mRNA independent of AREs, it interacts with an important ARE-binding protein, HuR, via shared UC-rich elements that can be recognized by both proteins. Interestingly, HuR binds to UC-rich elements in vivo, but direct binding with UC-rich motifs has not been observed in vitro (Myer et al., 1997) , suggesting that HuR may be recruited to these motifs through interaction with ''recruiters'' such as PCBP1 in vivo. Future studies will elucidate interactions between PCBP1 and other RBPs in regulating cytokine mRNA stability or in other post-transcriptional mechanisms.
Post-transcriptional mechanisms offer a swift mechanism for cells to respond to external challenges, including metabolic alteration. Prokaryotic cells can directly sense metabolite change through riboswitch and translation inhibition (Cheah et al., 2007) , whereas mammalian cells rely on a host of RBPs to regulate RNA processing in response to metabolic changes. Our study demonstrated that iron homeostasis, as one of the essential metabolic processes, participates in the post-transcriptional regulation of distinct classes of mRNAs in mammalian cells by interacting with RBPs. Future studies will identify other RBPs and their targets that are modulated by iron homeostasis or other metabolic pathways.
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EXPERIMENTAL MODEL AND SUBJECT DETAILS
Mice C57BL/6 mice were obtained from SLACCAS (Shanghai Laboratory Animal Center, CAS). 2D2 TCR transgenic mice were from Jackson lab and were kindly provided by Dr. Yang Sun at Nanjing University. Tfrc fl/fl mice were obtained from National Resource Center of Model Mice (Nanjing, China), and backcrossed to C57BL/6 background for over eight generations. Cd4-Cre, Rag1
À/À , Thy1.1 congenic mice and OT-II TCR transgenic mice in C57BL/C background were obtained from Jackson laboratory. All the mice were housed in specific pathogen free condition. In all experiments, young adult (6-8 weeks) female mice were used. All animal studies were performed in compliance with the guide for the care and use of laboratory animals and were approved by the institutional biomedical research ethics committee of the Shanghai Institutes for Biological Sciences. 
METHOD DETAILS
RNA extraction, cDNA synthesis and quantitative Real-Time PCR Total RNA was isolated with RNeasy plus kit (QIAGEN, CA) and cDNA was synthesized using PrimeScript TM RT reagent Kit with gDNA Eraser (TaKara, Japan). Quantitative PCR was performed using SYBR Premix Ex Taq (TaKara, Japan) on a StepOnePlus real-time PCR system (Life Tech, USA). Gene expression was normalized to GAPDH or b-actin using the DDCt method. Primer sequences were listed in Table S3 .
Lymphocyte Staining and Flow Cytometry
For cell surface staining, cells were washed with staining buffer (1% FBS in PBS with 0.1% NaN 3 ), and incubated with indicated antibodies on ice for 30 min. Cells were washed two more times with staining buffer and fixed in 1% paraformaldehyde in PBS before being analyzed with a Gallios machine (Beckman). For intracellular cytokine staining, cells were stimulated with phorbol 12-myristate 13-acetate (PMA, Sigma) (50 ng/ml)+ionomycin (Sigma) (500 ng/ml) for 6 h in the presence of Golgi-plug (BD Bioscience) at 37 C for the last four hours. Cells were then stained with live/dead cell staining (Fixable Aqua Dead Cell Stain Kit, Life Tech), fixed/permeabilized with a Cytofix/Cytoperm kit (BD Bioscience), and stained with antibodies against indicated cytokines.
To determine expression of PCBP1 or Ferritin, cells were first cytofixed and permeabilized (BD Bioscience), stained with respective primary antibodies (Pcbp1, Ferritin) followed by an APC-conjugated anti-Rabbit IgG (Life Tech).
To determine cell viability, cells were stained with Annexin V and PI (Annexin V Apoptosis Detection Kit I, BD Bioscience), and Annexin V -/PI -cells were determined as viable cells. To analyzed cytokine expression in human PBMC CD4 T cells, PBMC was isolated by Ficoll density gradient centrifugation from peripheral blood. The cells were then stimulated with PMA (50ng/ml)+ionomycin (500ng/ml)+Golgi-plug in the presence of CPX (20 mM) or DMSO at 37 C for 6 hours. The expression of cytokines in CD4 T cells was determined by intracellular flow cytometric staining.
MTT assay Primary Th1 cells were seeded and grown in 96-well plates at a density of 1 3 10 5 cells/well. Then DFO (50/100/200/400uM) were added to the medium. After 16 hours of treatments, MTT (1mg/ml) was added to all wells. The optical density (OD) of each well was then measured with a microplate spectrophotometer at 490 nm.
Cell trace violet staining and analysis
To analyze cell proliferation, CD4 T cells were purified and labeled with CellTrace Violet reagent (Life Tech), and were activated with anti-CD3+anti-CD28 and transduced with retrovirus containing a scramble sequence or shRNA against Pcbp1. Four days later, analysis was completed using Gallios machine with 405-nm excitation and a 450/40-nm bandpass emission filter.
OVA immunization 1 3 10 7 OTII CD4 T cells were intravenously transferred to 8-to 10-week-old C57BL/6 mice. One day later, mice were immunized subcutaneously at footpads with 25 mg OVA peptide in Aluminum-containing adjuvants containing 10ug lipopolysaccharide (Sigma).
EAE
To induce EAE by 2D2 TCR transgenic T cell, TCR-transgenic 2D2 T cells were purified and activated under Th1 conditions, and were transduced with indicated shRNAs in the pLMPd-Ametrine vector (Chen et al., 2014) . Five days after the initial activation, the cells were harvested and restimulated for 16-18 h with anti-CD3 and anti-CD28. Subsequently, 1-2 million Ametrine + cells were injected intraperitoneally into half-lethal irradiated (400 Rads) 6-to 8-wk-old recipient B6 mice. The recipients were monitored daily for development of experimental autoimmune encephalomyelitis. Clinical symptoms were measured according to the following criteria: 0, no disease; 1, decreased tail tone; 2, hind limb weakness or partial paralysis; 3, complete hind limb paralysis; 4, front and hind limb paralysis; 5, moribund.
To induce EAE by MOG-immunization, 8-to 10-week-old C57BL/6 mice were immunized subcutaneously at two sites on the back with 150 mg MOG (35-55) peptide in complete Freund's adjuvant containing Mycobacterium tuberculosis strain H37Ra (5 mg/ml; Difco). Mice were injected intraperitoneally on days 0 and day 2 with 200 ng pertussis toxin (Sigma) in PBS.
To Isolate of CNS-infiltrating cells, recipients were euthanized and perfused at the indicated time. CNS-infiltrating mononuclear cells were recovered from the brain and the spinal cord, and isolated with Percoll gradient centrifugation. Isolated cells were re-stimulated with PMA and Ionomcyin before intracellular cytokine staining to determine cytokine production.
To induce iron overload in vivo, three days after the 2D2 T cell transfer, the recipient mice were injected intraperitoneally with PBS or iron dextran (5mg) and NAC (4mg) every three days for 15 days.
Bone marrow chimera
Bone marrow cells were isolated from C57BL/6 mice pre-treated with 5-fluorouracil (150mg/kg) three days before collection. The cells were cultured in DMEM with IL-3 (10 ng/mL), IL-6 (20 ng/mL), and Scf. (50 ng/mL) and transduced with retrovirus containing the indicated shRNAs in the LMP vector at 20 and 40 h after culture. Puromycin (2 mg/mL) was added to the culture on day 3. Cells were harvested on day 5, and 2-5 3 10 6 cells were i.v. injected into Rag1 À/À mice that had been sublethally irradiated (400 rad) 1 d before cell transfer. Chimeric mice were analyzed 6-8 weeks after the transplantation.
Acute depletion of Tfrc in 2D2 T cells in vivo CD4 T cells from 2D2 Tfrc fl/fl mice were stimulated as above and transduced with retrovirus containing a self-deleting Cre-ER cassette (LGmCreER (self deleting) was a gift from Scott Lowe (Addgene plasmid # 33340)). The cells were transferred into irradiated WT recipients to induce EAE. When the mice reached EAE clinical score 1, the mice were randomly divided into two groups, which were treated with either corn oil or tamoxifen (100mg/kg) daily for four days. To analyze Tfrc deficiency in EAE pathogenesis, either wild-type 2D2 or 2D2 Tfrc fl/fl cells were transduced with the LGmCreER retrovirus, and transferred into irradiated mice. All the mice were subsequently treated with tamoxifen (100mg/kg) daily for four days.
T cell culture and differentiation To purify CD4 T cells, splenocytes and lymph node cells were stained with a biotin conjugated anti-CD4 antibody to enrich CD4 T cells using a magnetic Biotin-selection kit (Stem cell). Purified CD4 T cells were activated with plate-bound anti-Hamster IgG (MP Biomedicals) and anti-CD3 (2C11, Bio X cell) +anti-CD28 (37N, Bio X cell) in the presence of anti-IL-4 (5 mg/ml; 11B11, Bio X cell) and IL-12 (2 ng/ml; PeproTech) in T cell medium (RPMI 1640, 10% FBS, 1x antibiotics, 1x non-essential amino acid and 50 mM b-mercaptoethanol).
Retroviral and lentiviral infection
Retrovirus was produced by transfecting Plat-E cells with indicated plasmids, and supernatant containing fresh virus was collected and used to infect T cells. To infect T cells, naïve T cells were first stimulated with anti-CD3 and anti-CD28. The activated T cells were spin-infected for 1.5 hours at 2000 rpm in the presence of polybrene (8 mg/ml) twice at 18 hours and 40 hours post-activation, and were cultured at 37 C for 2 additional hours before being re-suspended in the indicated T cell differentiation medium. Lentivirus was generated by transfecting 293T cells with pLKO.1, VSVG and psPAX2 plasmids. Jurkat cells with the GM-CSF 3 0 UTR reporter were transfected with pLKO.1 shRNA lentivirus targeting selected RBPs and selected with Puromycin (2 mg/ml) for 6 days. Then GFP expression was analyzed by flow cytometry and Mean Fluorescent Intensity (MFI) was determined. Total 288 clones for 79 human RBPs were screened. Data were normalized by dividing MFI of cells transduced with the indicated shRNA to the cells transduced with a scramble sequence, and z-score was calculated in each experiment.
RNA seq analysis
For transcriptome analysis of Th1 cells, total RNA was extracted after 4-hour PMA+ionomycin stimulation. To analyze the transcriptome change caused by iron depletion, WT Th1 cells were treated with CPX (20 mM) or DMSO together with PMA and ionomycin for four hours. Two pairs of samples from two independent experiments were included for analysis. Ribosome RNA was depleted and RNA seq libraries were prepared using TruSeq Stranded Total RNA with Ribo-Zero Human/Mouse/Rat kit (Illumina), and sequenced on a Hiseq 2000 platform or Hiseq X-10 platform. RNA seq reads were first mapped to mm9 with STAR (Dobin et al., 2013) , and differential gene expression (RPKM) analysis was conducted by Deseq analysis. Heatmap was generated with Cluster3 and Java Treeview (Saldanha, 2004) , and genes and samples were clustered with hierarchical clustering. Gene ontology analysis was done using David (Huang et al., 2009 CLIP analysis PCBP1 CLIP experiments were conducted in Jurkat T cells with a recently published optimized protocol (Van Nostrand et al., 2016) . Briefly, Jurkat T cells were UV crosslinked, lysed and treated with RNase I. PCBP1-RNA complex was immunoprecipitated with an anti-PCBP1 antibody (MPL), and was resolved on 4%-12% LDS gel with MOPS buffer (Life Tech). RNA on the gel was visualized with SYBR green I staining on the Chemi Doc (QIAGEN). RNA bound to PCBP1 was extracted from the gel, freed from protein by digestion with proteinase K, purified, converted into cDNA, and sequenced by using an Illumina Hiseq sequencer (paired-end 50-bp reads) (Van Nostrand et al., 2016) . To identify PCBP1 binding sites, adaptor sequences were first clipped with Cutadapt, and were mapped to the human genome (hg19) with STAR (Dobin et al., 2013) . PCR duplication was removed, and unique mapped reads were used for PCBP1 binding cluster analysis with CLIPper (Lovci et al., 2013) . For PAR-CLIP analysis of PCBP1-binding sites in Th1 cells, Th1 cells were pulsed with 4SU (100 mM; Sigma) overnight and restimulated with PMA and ionomycin for 6 hours. CLIP libraries were conducted as described (Chang et al., 2015) . The sequence reads were trimmed with Cutadpt, and then mapped to mm9 with STAR. The binding sites were derived with PARalyzer 2.0 with following parameters: (bandwidth = 3;conversion = t > c; minimum_read_count_per_group = 8;minimum_read_count_per_cluster = 1;minimum_read_count_for_kde = 5;minimum_cluster_size = 1;minimum_conversion_locations_for_cluster = 1;minimum_conversion_ count_for_cluster = 1;minimum_read_count_for_cluster_inclusion = 1;minimum_read_length = 10;maximum_number_of_non_ conversion_mismatches = 5). The derived clusters were assigned to specific genome category with Homer (Heinz et al., 2010) . Motif analysis was done using HOMER with the default parameters for RNA.
mRNA half-life analysis by 4SU pulse-chase experiments Jurkat cells or primary Th1 cells were stimulated with PMA and ionomycin in the presence of 25 mM 4-SU (Sigma) for 6 hours. The cells were washed with PBS, replenished with the fresh medium and incubated for 0, 30, 60, 90, and 120 minutes. At each time point, RNA was extracted and 4SU labeled RNA was captured with EZ-Link Biotin-HPDP (Pierce) and Dynalbeads MyOne Streptavidin T1 (Life Tech). To analyzing the RNA decay in iron-depleting conditions, WT Jurkat cells were stimulated as above, and CPX (200 mM) was added into the fresh culture medium at the chasing period two hours before collection. The biotinylated RNA was reverse transcribed into cDNA, and quantified with Real-Time PCR.
Luciferase Assay 293T cells were transfected with pGL3-hGM-CSF 3 0 UTR in the presence of pCMV6-Full Length PCBP1 or the domain depleting mutants together with a Renilla expressing vector (pRL). 48 h after the transfection, activity of firefly luciferase (FL) and Renilla luciferase (RL) was determined with a dual-luciferase reporter assay (Promega), and FL activity was normalized to RL activity. To measure GM-CSF 3 0 UTR activity in primary CD4 T cells, pCDNA-hGM-CSF 3 0 UTR vector was delivered into CD4+ T cells by Neon Transfection System (Life Tech). 12 h after the electrotransfection, CPX (50uM) was added into the medium for 10 hours, and activity of (FL) and RL was determined as above.
Polyribosome profiling analysis.
Jurkat cells with the hCSF2-3 0 UTR reporter were cultured in the presence of 100 mg/ml cycloheximide (CHX) at 37 C for 10 min. Cells were washed twice with cold PBS containing 100 mg/ml CHX before being lysed on ice for 10 min. Cell lysate was centrifuged at 13,000 rpm for 10 min at 4 C, and the supernatant containing cytoplasmic proteins were layered on top of a linear 10%-to-50% (wt/vol) sucrose gradient. After centrifugation at 40,000 rpm for 3 h at 4 C, 12 fractions (900 mL each) were collected from the top of the gradient. RNA in each fraction was extracted with TRIzol, and presence of GFP-(hCSF2) 3 0 UTR fusion mRNA was determined by RT-PCR as described above.
RIP assay.
Jurkat cells were stimulated with PMA plus Ionomycin for 6 hours. The cells were lysed with RIPA buffer and immunoprecipitation was performed with an anti-PCBP1 antibody (MBL) or Normal rabbit IgG, and Protein A Dynal beads. RNA was extracted and used to perform real-time PCR with specific primers.
Plasmids
To generate CSF2 3 0 UTR-MIGR1 or CSF2 3 0 UTR-pBMN DHFR(DD)-YFP plasmids, CSF2 3 0 UTR was amplified from human cDNA and inserted between PacI and SalI sites of MIGR1 or NotI sites of pBMN DHFR(DD)-YFP vector (Addgene # 29325). For luciferase reporter plasmids, CSF2 3 0 UTR sequence was inserted between the XbalI sites of pGL3 basic vector (Promega). The core ARE sequence (46bp) was deleted by overlapping PCR to construct the CSF2 3 0 UTR DARE plasmid.
pLKO.1 shRNA plamids were obtained from Sigma Aldrich, and used for RBP screening in CSF2 3 0 UTR reporter cells and knockdown assays in Jurkat cells. To transduce primary mouse CD4 T cells, shPcbp1 sequence from GIPZ Lentiviral shRNA (obtained from Sigma Aldrich) was cloned into MSCV-LTRmiR30-PIG (LMP) (Dharmacon) or MSCV-LTRmiR30-Ametrine vectors.
LGmCreER (self deleting) was a gift from Scott Lowe (Addgene plasmid # 33340).
Full length PCBP1 was amplified from human cDNA and inserted into either PCMV6 or MSCV vectors. Mutants with individual KH domain deletion was generated by overlapping PCR.
QUANTIFICATION AND STATISTICAL ANALYSIS
Statistical analysis
Statistical parameters are all reported in Figure Legends . Statistical analysis was performed using two-tailed Student's t tests, twoway ANOVA, Kolmogorov-Smirnov Test (one/two-sided) or two-way Fisher's exact test in GraphPad Prism.
DATA AND SOFTWARE AVAILABILITY
The data generated in this paper has been deposited in the GEO under accession number GEO: GSE84702.
